Jpmorgan Global Emerging Markets .../ GB00B5ZZY915 /
30.05.2024 21:00:00 | Diff. -2,5000 | Volumen | Geld30.05.2024 | Brief30.05.2024 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
132,0000GBX | -1,86% | 33.174 Umsatz(GBP): 43.873,7500 |
-Geld Vol: - | -Brief Vol: - | 392,49 Mio.GBP | - | - |
GlobeNewswire
22:05
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
22:05
IndyCar Driver Marcus Armstrong to Represent Root Insurance at Detroit Grand Prix
GlobeNewswire
22:05
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of P...
GlobeNewswire
22:05
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedr...
GlobeNewswire
22:05
Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
GlobeNewswire
22:05
Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Stu...
GlobeNewswire
22:05
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
GlobeNewswire
22:05
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq ...
GlobeNewswire
22:05
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
GlobeNewswire
22:05
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire
22:03
PATH (NYSE) INVESTIGATION ALERT: BFA Law Announces Investigation into UiPath, Inc., Encourages Inves...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite